Medite Cancer Diagnostics
Orlando, US · Delaware corporation
Find your way into Medite Cancer Diagnostics
Sign up to see every warm intro you have to Medite Cancer Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medite Cancer Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
AF
Alexander F. MilleyBoard director
JA
John AbelesBoard director
MS
Mauro ScimiaBoard director
AO
Augusto OcanaBoard director
XC
Xavier CarbonellBoard director
Reported raises · per SEC filings
Form D private placements$12.4M disclosed across 10 rounds · 2014–2018
▶$870KraisedOct 2018 · 3 investors · Other Health CareRule 506(b)
▶$870KraisedOct 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Abeles, MDDirector
- William Austin Lewis IVDirector
- Joel KanterDirector
- Stephen Von RumpExecutive Officer, Director, Promoter
- Gary PickettExecutive Officer
- Gregory FortunoffDirector
- Offering amount
- $1M
- Amount sold
- $870K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$850KraisedJul 2018 · 2 investors · Other Health CareRule 506(b)
▶$850KraisedJul 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Lawrence Von RumpExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $850K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedFeb 2018 · 5 investors · Other Health CareRule 506(b)
▶$1.2MraisedFeb 2018 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Abeles, MDDirector
- Stephen Eugene Von RumpExecutive Officer, Director
- Gregory FortunoffDirector
- William Austin Lewis IVDirector
- Joel Eugene KanterDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedOct 2017 · 6 investors · Other Health CareRule 506(b)
▶$5.9MraisedOct 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William Austin Lewis IVDirector
- David Eugene PattersonExecutive Officer, Director, Promoter
- Michaela OttDirector
- Augusto Eugene OcanaDirector
- Eric GoehausenDirector
- John Abeles, MDDirector
- Michael OttDirector
- Offering amount
- $6.9M
- Amount sold
- $5.9M
- Minimum investment
- $25K
- Sales commissions
- $281.9K
- Placement agents
- Tripoint Global Equities, LLC
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$555KraisedMar 2017 · 8 investors · Other Health CareRule 506(b)
▶$555KraisedMar 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric GoehausenDirector
- Augusto Eugene OcanaDirector
- John Abeles, MDDirector
- Michael OttDirector
- William Austin Lewis IVDirector
- Michaela OttExecutive Officer, Director
- David Eugene PattersonExecutive Officer, Director
- Offering amount
- $4.3M
- Amount sold
- $555K
- Minimum investment
- $25K
- Sales commissions
- $41.6K
- Placement agents
- Tripoint Global Equities, LLC
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$411.9KraisedFeb 2017 · 5 investors · Other Health CareRule 506(b)
▶$411.9KraisedFeb 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William Austin Lewis IVDirector
- Michaela OttExecutive Officer, Director
- Michael OttDirector
- John Abeles, MDDirector
- Augusto Eugene OcanaDirector
- David Eugene PattersonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $411.9K
- Minimum investment
- $50K
- Sales commissions
- $30.9K
- Placement agents
- Tripoint Global Equities, LLC, John D. Colwell
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedNov 2016 · 7 investors · Other Health CareRule 506(b)
▶$400KraisedNov 2016 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David Eugene PattersonExecutive Officer, Director
- Robert Francis McCulloughExecutive Officer, Director
- Michaela OttExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $50K
- Sales commissions
- $210K
- Placement agents
- TriPoint Global Equities, LLC
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150KraisedJun 2016 · 2 investors · Other Health CareRule 506(b)
▶$150KraisedJun 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michaela OttExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- Minimum investment
- $50K
- Sales commissions
- $8.1K
- Placement agents
- TriPoint Global Equities, LLC
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Medite Cancer Diagnostics raised?
- Medite Cancer Diagnostics has disclosed $12.4M raised across 10 rounds.
- Where is Medite Cancer Diagnostics headquartered?
- Medite Cancer Diagnostics is headquartered in Orlando, US.